An expanding spectrum of complications in isolated methylmalonic aciduria

1Fowler B, Leonard JV, Baumgartner MR. Causes of and diagnostic approach to methylmalonic acidurias. J Inherit Metab Dis. 2008;31(3):350–60. doi:10.1007/s10545-008-0839-4. Fowler B Leonard JV Baumgartner MR Causes of and diagnostic approach to methylmalonic acidurias J Inherit Metab Dis 200831335060 10.1007/s10545-008-0839-418563633Open DOISearch in Google Scholar

2Froese DS, Fowler B, Baumgartner MR. Vitamin B12, folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation. J Inherit Metab Dis. 2019;42(4):673–85. doi:10.1002/jimd.12009. Froese DS Fowler B Baumgartner MR Vitamin B12, folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation J Inherit Metab Dis 201942467385 10.1002/jimd.1200930693532Open DOISearch in Google Scholar

3Hörster F, Garbade SF, Zwickler T, Aydin HI, Bodamer OA, Burlina AB, et al. Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters. J Inherit Metab Dis. 2009;32(5):630. doi:10.1007/s10545-009-1189-6. Epub 2009 Jul 31. Erratum in: J Inherit Metab Dis. 2009;32(6):762–3. Hörster F Garbade SF Zwickler T Aydin HI Bodamer OA Burlina AB et al Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters J Inherit Metab Dis 2009325630 10.1007/s10545-009-1189-6 Epub 2009 Jul 31. Erratum in: J Inherit Metab Dis. 2009;32(6):762–319642010Open DOISearch in Google Scholar

4Kölker S, Garcia-Cazorla A, Valayannopoulos V, Lund AM, Burlina AB, Sykut-Cegielska J, et al. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. J Inherit Metab Dis. 2015;38(6):1041–57. doi:10.1007/s10545-015-9839-3. Erratum in: J Inherit Metab Dis. 2015;38(6):1155–6. Cazorla, Angeles Garcia [corrected to Garcia-Cazorla, Angeles]. Kölker S Garcia-Cazorla A Valayannopoulos V Lund AM Burlina AB Sykut-Cegielska J et al The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation J Inherit Metab Dis 2015386104157 10.1007/s10545-015-9839-3 Erratum in: J Inherit Metab Dis. 2015;38(6):1155–6. Cazorla, Angeles Garcia [corrected to Garcia-Cazorla, Angeles]25875215Open DOISearch in Google Scholar

5Baumgartner MR, Hörster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA, et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9:130. doi:10.1186/s13023-014-0130-8. Baumgartner MR Hörster F Dionisi-Vici C Haliloglu G Karall D Chapman KA et al Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia Orphanet J Rare Dis 20149130 10.1186/s13023-014-0130-8418031325205257Open DOISearch in Google Scholar

6Oberholzer VG, Levin B, Burgess EA, Young WF. Methylmalonic aciduria. An inborn error of metabolism leading to chronic metabolic acidosis. Arch Dis Child. 1967;42(225):492–504. doi:10.1136/adc.42.225.492. Oberholzer VG Levin B Burgess EA Young WF Methylmalonic aciduria. An inborn error of metabolism leading to chronic metabolic acidosis Arch Dis Child 196742225492504 10.1136/adc.42.225.49220198056061291Open DOISearch in Google Scholar

7Hörster F, Baumgartner MR, Viardot C, Suormala T, Burgard P, Fowler B, et al. Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Pediatr Res. 2007;62(2):225–30. doi:10.1203/PDR.0b013e3180a0325f. Hörster F Baumgartner MR Viardot C Suormala T Burgard P Fowler B et al Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB) Pediatr Res 200762222530 10.1203/PDR.0b013e3180a0325f17597648Open DOISearch in Google Scholar

8Kölker S, Valayannopoulos V, Burlina AB, Sykut-Cegielska J, Wijburg FA, Teles EL, et al. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype. J Inherit Metab Dis. 2015;38(6):1059–74. doi:10.1007/s10545-015-9840-x. Erratum in: J Inherit Metab Dis. 2015;38(6):1157–8. Garcia Cazorla, Angeles [corrected to Garcia-Cazorla, Angeles]. Kölker S Valayannopoulos V Burlina AB Sykut-Cegielska J Wijburg FA Teles EL et al The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype J Inherit Metab Dis 2015386105974 10.1007/s10545-015-9840-x Erratum in: J Inherit Metab Dis. 2015;38(6):1157–8. Garcia Cazorla, Angeles [corrected to Garcia-Cazorla, Angeles]25875216Open DOISearch in Google Scholar

9Haijes HA, Jans JJM, Tas SY, Verhoeven-Duif NM, van Hasselt PM. Pathophysiology of propionic and methylmalonic acidemias. Part 1: complications. J Inherit Metab Dis. 2019;42(5):730–44. doi:10.1002/jimd.12129. Haijes HA Jans JJM Tas SY Verhoeven-Duif NM van HasseltPM Pathophysiology of propionic and methylmalonic acidemias. Part 1: complications J Inherit Metab Dis 201942573044 10.1002/jimd.1212931119747Open DOISearch in Google Scholar

10Kruszka PS, Manoli I, Sloan JL, Kopp JB, Venditti CP. Renal growth in isolated methylmalonic acidemia. Genet Med. 2013;15(12):990–6. doi:10.1038/gim.2013.42. Kruszka PS Manoli I Sloan JL Kopp JB Venditti CP Renal growth in isolated methylmalonic acidemia Genet Med 201315129906 10.1038/gim.2013.42414905723639900Open DOISearch in Google Scholar

11Cosson MA, Benoist JF, Touati G, Déchaux M, Royer N, Grandin L, et al. Long-term outcome in methylmalonic aciduria: a series of 30 French patients. Mol Genet Metab. 2009;97(3):172–8. doi:10.1016/j.ymgme.2009.03.006. Cosson MA Benoist JF Touati G Déchaux M Royer N Grandin L et al Long-term outcome in methylmalonic aciduria: a series of 30 French patients Mol Genet Metab 20099731728 10.1016/j.ymgme.2009.03.00619375370Open DOISearch in Google Scholar

12Noone D, Riedl M, Atkison P, Avitzur Y, Sharma AP, Filler G, et al. Kidney disease and organ transplantation in methylmalonic acidaemia. Pediatr Transplant. 2019;23(4):e13407. doi:10.1111/petr.13407. Noone D Riedl M Atkison P Avitzur Y Sharma AP Filler G et al Kidney disease and organ transplantation in methylmalonic acidaemia Pediatr Transplant 2019234e13407 10.1111/petr.1340730973671Open DOISearch in Google Scholar

13Luciani A, Schumann A, Berquez M, Chen Z, Nieri D, Failli M, et al. Impaired mitophagy links mitochondrial disease to epithelial stress in methylmalonyl-CoA mutase deficiency. Nat Commun. 2020;11(1):970. doi:10.1038/s41467-020-14729-8. Erratum in: Nat Commun. 2020;11(1):1719. 10.1038/s41467-020-15565-6. Luciani A Schumann A Berquez M Chen Z Nieri D Failli M et al Impaired mitophagy links mitochondrial disease to epithelial stress in methylmalonyl-CoA mutase deficiency Nat Commun 2020111970 10.1038/s41467-020-14729-8 Erratum in: Nat Commun. 2020;11(1):1719. 10.1038/s41467-020-15565-6703313732080200Open DOISearch in Google Scholar

14de Keyzer Y, Valayannopoulos V, Benoist JF, Batteux F, Lacaille F, Hubert L, et al. Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr Res. 2009;66(1):91–5. doi:10.1203/PDR.0b013e3181a7c270. de KeyzerY ValayannopoulosV BenoistJF BatteuxF LacailleF HubertL et al Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria Pediatr Res 2009661915 10.1203/PDR.0b013e3181a7c27019342984Open DOISearch in Google Scholar

15Manoli I, Sysol JR, Li L, Houillier P, Garone C, Wang C, et al. Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemia. Proc Natl Acad Sci U S A. 2013;110(33):13552–7. doi:10.1073/pnas.1302764110. Manoli I Sysol JR Li L Houillier P Garone C Wang C et al Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemia Proc Natl Acad Sci U S A 201311033135527 10.1073/pnas.1302764110374687523898205Open DOISearch in Google Scholar

16Haarmann A, Mayr M, Kölker S, Baumgartner ER, Schnierda J, Hopfer H, et al. Renal involvement in a patient with cobalamin A type (cblA) methylmalonic aciduria: a 42-year follow-up. Mol Genet Metab. 2013;110(4):472–6. doi:10.1016/j.ymg-me.2013.08.021. Haarmann A Mayr M Kölker S Baumgartner ER Schnierda J Hopfer H et al Renal involvement in a patient with cobalamin A type (cblA) methylmalonic aciduria: a 42-year follow-up Mol Genet Metab 201311044726 10.1016/j.ymg-me.2013.08.021Open DOISearch in Google Scholar

17Prada CE, Al Jasmi F, Kirk EP, Hopp M, Jones O, Leslie ND, et al. Cardiac disease in methylmalonic acidemia. J Pediatr. 2011;159(5):862-864. doi:10.1016/j.jpeds.2011.06.005. Prada CE Al Jasmi F Kirk EP Hopp M Jones O Leslie ND et al Cardiac disease in methylmalonic acidemia J Pediatr 20111595862 864 10.1016/j.jpeds.2011.06.00521784454Open DOISearch in Google Scholar

18Vatanavicharn N, Champattanachai V, Liammongkolkul S, Sawangareetrakul P, Keeratichamroen S, Ketudat Cairns JR, et al. Clinical and molecular findings in Thai patients with isolated methylmalonic acidemia. Mol Genet Metab. 2012;106(4):424–9. doi:10.1016/j.ymgme.2012.05.012. Vatanavicharn N Champattanachai V Liammongkolkul S Sawangareetrakul P Keeratichamroen S Ketudat Cairns JR et al Clinical and molecular findings in Thai patients with isolated methylmalonic acidemia Mol Genet Metab 201210644249 10.1016/j.ymgme.2012.05.01222695176Open DOISearch in Google Scholar

19Ktena YP, Paul SM, Hauser NS, Sloan JL, Gropman A, Manoli I, et al. Delineating the spectrum of impairments, disabilities, and rehabilitation needs in methylmalonic acidemia (MMA). Am J Med Genet A. 2015;167A(9):2075–84. doi:10.1002/ajmg.a.37127. Ktena YP Paul SM Hauser NS Sloan JL Gropman A Manoli I et al Delineating the spectrum of impairments, disabilities, and rehabilitation needs in methylmalonic acidemia (MMA) Am J Med Genet A 2015167A92075–84 10.1002/ajmg.a.37127901724425959030Open DOISearch in Google Scholar

20de Baulny HO, Benoist JF, Rigal O, Touati G, Rabier D, Saudubray JM. Methylmalonic and propionic acidaemias: management and outcome. J Inherit Metab Dis. 2005;28(3):415–23. doi:10.1007/s10545-005-7056-1. de BaulnyHO BenoistJF RigalO TouatiG RabierD SaudubrayJM Methylmalonic and propionic acidaemias: management and outcome J Inherit Metab Dis 200528341523 10.1007/s10545-005-7056-115868474Open DOISearch in Google Scholar

21Kahler SG, Millington DS, Cederbaum SD, Vargas J, Bond LD, Maltby DA, et al. Parenteral nutrition in propionic and methyl-malonic acidemia. J Pediatr. 1989;115(2):235–41. doi:10.1016/s0022-3476(89)80071-x. Kahler SG Millington DS Cederbaum SD Vargas J Bond LD Maltby DA et al Parenteral nutrition in propionic and methyl-malonic acidemia J Pediatr 1989115223541 10.1016/s0022-3476(89)80071-xOpen DOISearch in Google Scholar

22Marquard J, El Scheich T, Klee D, Schmitt M, Meissner T, Mayatepek E, et al. Chronic pancreatitis in branched-chain organic acidurias – a case of methylmalonic aciduria and an overview of the literature. Eur J Pediatr. 2011;170(2):241–5. doi:10.1007/s00431-010-1313-5. Marquard J El Scheich T Klee D Schmitt M Meissner T Mayatepek E et al Chronic pancreatitis in branched-chain organic acidurias – a case of methylmalonic aciduria and an overview of the literature Eur J Pediatr 201117022415 10.1007/s00431-010-1313-520924605Open DOISearch in Google Scholar

23Thul PJ, Akesson L, Wiking M, Mahdessian D, Geladaki A, Blal H, et al. A subcellular map of the human proteome. Science (New York, N.Y.). 2017;356(6340):eaal3321. doi:10.1126/science. aal3321. Thul PJ Akesson L Wiking M Mahdessian D Geladaki A Blal H et al A subcellular map of the human proteome Science (New York, N.Y.) 20173566340eaal3321 10.1126/science.aal332128495876Open DOISearch in Google Scholar

24Brassier A, Krug P, Lacaille F, Pontoizeau C, Krid S, Sissaoui S, et al. Long-term outcome of methylmalonic aciduria after kidney, liver, or combined liver-kidney transplantation: the French experience. J Inherit Metab Dis. 2020;43(2):234–43. doi:10.1002/jimd.12174. Brassier A Krug P Lacaille F Pontoizeau C Krid S Sissaoui S et al Long-term outcome of methylmalonic aciduria after kidney, liver, or combined liver-kidney transplantation: the French experience J Inherit Metab Dis 202043223443 10.1002/jimd.1217431525265Open DOISearch in Google Scholar

25Imbard A, Garcia Segarra N, Tardieu M, Broué P, Bouchereau J, Pichard S, et al. Long-term liver disease in methylmalonic and propionic acidemias. Mol Genet Metab. 2018;123(4):433–40. doi:10.1016/j.ymgme.2018.01.009. Imbard A Garcia Segarra N Tardieu M Broué P Bouchereau J Pichard S et al Long-term liver disease in methylmalonic and propionic acidemias Mol Genet Metab 2018123443340 10.1016/j.ymgme.2018.01.00929433791Open DOISearch in Google Scholar

26Forny P, Hochuli M, Rahman Y, Deheragoda M, Weber A, Baruteau J, et al. Liver neoplasms in methylmalonic aciduria: an emerging complication. J Inherit Metab Dis. 2019;42(5):793–802. doi:10.1002/jimd.12143. Forny P Hochuli M Rahman Y Deheragoda M Weber A Baruteau J et al Liver neoplasms in methylmalonic aciduria: an emerging complication J Inherit Metab Dis 2019425793802 10.1002/jimd.1214331260114Open DOISearch in Google Scholar

27Cosson MA, Touati G, Lacaille F, Valayannnopoulos V, Guyot C, Guest G, et al. Liver hepatoblastoma and multiple OXPHOS deficiency in the follow-up of a patient with methylmalonic aciduria. Mol Genet Metab. 2008;95(1–2):107–9. doi:10.1016/j.ymg-me.2008.06.007. Cosson MA Touati G Lacaille F Valayannnopoulos V Guyot C Guest G et al Liver hepatoblastoma and multiple OXPHOS deficiency in the follow-up of a patient with methylmalonic aciduria Mol Genet Metab 2008951–21079 10.1016/j.ymg-me.2008.06.007Open DOISearch in Google Scholar

28Chan R, Mascarenhas L, Boles RG, Kerkar N, Genyk Y, Venkatramani R. Hepatoblastoma in a patient with methylmalonic aciduria. Am J Med Genet A. 2015;167A(3):635–8. doi:10.1002/ajmg.a.36925. Chan R Mascarenhas L Boles RG Kerkar N Genyk Y Venkatramani R Hepatoblastoma in a patient with methylmalonic aciduria Am J Med Genet A 2015167A36358 10.1002/ajmg.a.3692525691417Open DOISearch in Google Scholar

29Nicolaides P, Leonard J, Surtees R. Neurological outcome of methylmalonic acidaemia. Arch Dis Child. 1998;78(6):508–12. doi:10.1136/adc.78.6.508. Nicolaides P Leonard J Surtees R Neurological outcome of methylmalonic acidaemia Arch Dis Child 199878650812 10.1136/adc.78.6.50817175929713004Open DOISearch in Google Scholar

30Martín-Hernández E, Lee PJ, Micciche A, Grunewald S, Lachmann RH. Long-term needs of adult patients with organic acidaemias: outcome and prognostic factors. J Inherit Metab Dis. 2009;32(4):523–33. doi:10.1007/s10545-009-1191-12. Martín-Hernández E LeePJ MiccicheA GrunewaldS LachmannRH Long-term needs of adult patients with organic acidaemias: outcome and prognostic factors J Inherit Metab Dis 200932452333 10.1007/s10545-009-1191-1219629744Open DOISearch in Google Scholar

31O’Shea CJ, Sloan JL, Wiggs EA, Pao M, Gropman A, Baker EH, et al. Neurocognitive phenotype of isolated methylmalonic acidemia. Pediatrics. 2012;129(6):e1541–51. doi:10.1542/peds.2011-1715. O’Shea CJ Sloan JL Wiggs EA Pao M Gropman A Baker EH et al Neurocognitive phenotype of isolated methylmalonic acidemia Pediatrics 20121296e154151 10.1542/peds.2011-1715336290322614770Open DOISearch in Google Scholar

32Wajner M. Neurological manifestations of organic acidurias. Nat Rev Neurol. 2019;15(5):253–71. doi:10.1038/s41582-019-0161-9. Wajner M Neurological manifestations of organic acidurias Nat Rev Neurol 201915525371 10.1038/s41582-019-0161-930914790Open DOISearch in Google Scholar

33Pinar-Sueiro S, Martínez-Fernández R, Lage-Medina S, Al-damiz-Echevarria L, Vecino E. Optic neuropathy in methylmalonic acidemia: the role of neuroprotection. J Inherit Metab Dis. 2010;33(Suppl 3):S199–203. doi:10.1007/s10545-010-9084-8. Pinar-Sueiro S Martínez-FernándezR Lage-MedinaS Al-damiz-EchevarriaL VecinoE Optic neuropathy in methylmalonic acidemia: the role of neuroprotection J Inherit Metab Dis 201033Suppl 3S199203 10.1007/s10545-010-9084-820449661Open DOISearch in Google Scholar

34Manoli I, Myles JG, Sloan JL, Shchelochkov OA, Venditti CP. A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 1: isolated methylmalonic acidemias. Genet Med. 2016;18(4):386–95. doi:10.1038/gim.2015.102. Manoli I Myles JG Sloan JL Shchelochkov OA Venditti CP A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 1: isolated methylmalonic acidemias Genet Med 201618438695 10.1038/gim.2015.102475292526270765Open DOISearch in Google Scholar

35van der Meer SB, Poggi F, Spada M, Bonnefont JP, Ogier H, Hubert P, et al. Clinical outcome and long-term management of 17 patients with propionic acidaemia. Eur J Pediatr. 1996;155(3):205–10. doi:10.1007/BF01953939. van der MeerSB PoggiF SpadaM BonnefontJP OgierH HubertP et al Clinical outcome and long-term management of 17 patients with propionic acidaemia Eur J Pediatr 1996155320510 10.1007/BF019539398929729Open DOISearch in Google Scholar

36Yannicelli S, Acosta PB, Velazquez A, Bock HG, Marriage B, Kurczynski TW, et al. Improved growth and nutrition status in children with methylmalonic or propionic acidemia fed an elemental medical food. Mol Genet Metab. 2003;80(1–2):181–8. doi:10.1016/j. ymgme.2003.08.012. Yannicelli S Acosta PB Velazquez A Bock HG Marriage B Kurczynski TW et al Improved growth and nutrition status in children with methylmalonic or propionic acidemia fed an elemental medical food Mol Genet Metab 2003801–21818 10.1016/j.ymgme.2003.08.01214567967Open DOISearch in Google Scholar

37Molema F, Gleich F, Burgard P, van der Ploeg AT, Summar ML, Chapman KA, et al.; Additional individual contributors from E-IMD. Evaluation of dietary treatment and amino acid supplementation in organic acidurias and urea-cycle disorders: on the basis of information from a European multicenter registry. J Inherit Metab Dis. 2019;42(6):1162–75. doi:10.1002/jimd.12066. Molema F Gleich F Burgard P van der Ploeg AT Summar ML Chapman KA et al Additional individual contributors from E-IMD. Evaluation of dietary treatment and amino acid supplementation in organic acidurias and urea-cycle disorders: on the basis of information from a European multicenter registry J Inherit Metab Dis 2019426116275 10.1002/jimd.1206630734935Open DOISearch in Google Scholar

38Touati G, Valayannopoulos V, Mention K, de Lonlay P, Jouvet P, Depondt E, et al. Methylmalonic and propionic acidurias: management without or with a few supplements of specific amino acid mixture. J Inherit Metab Dis. 2006;29(2–3):288–98. doi:10.1007/s10545-006-0351-7. Touati G Valayannopoulos V Mention K de Lonlay P Jouvet P Depondt E et al Methylmalonic and propionic acidurias: management without or with a few supplements of specific amino acid mixture J Inherit Metab Dis 2006292–328898 10.1007/s10545-006-0351-716763890Open DOISearch in Google Scholar

39Diodato D, Olivieri G, Pro S, Maiorani D, Martinelli D, Deodato F, et al. Axonal peripheral neuropathy in propionic acidemia: a severe side effect of long-term metronidazole therapy. Neurology. 2018;91(12):565–7. doi:10.1212/WNL.0000000000006209. Diodato D Olivieri G Pro S Maiorani D Martinelli D Deodato F et al Axonal peripheral neuropathy in propionic acidemia: a severe side effect of long-term metronidazole therapy Neurology 201891125657 10.1212/WNL.000000000000620930120134Open DOISearch in Google Scholar

40Goolsby TA, Jakeman B, Gaynes RP. Clinical relevance of metronidazole and peripheral neuropathy: a systematic review of the literature. Int J Antimicrob Agents. 2018;51(3):319–25. doi:10.1016/j.ijantimicag.2017.08.033. Goolsby TA Jakeman B Gaynes RP Clinical relevance of metronidazole and peripheral neuropathy: a systematic review of the literature Int J Antimicrob Agents 201851331925 10.1016/j.ijantimicag.2017.08.03328887203Open DOISearch in Google Scholar

41Alston TA, Abeles RH. Enzymatic conversion of the antibiotic metronidazole to an analog of thiamine. Arch Biochem Biophys. 1987;257(2):357–62. doi:10.1016/0003-9861(87)90577-7. Alston TA Abeles RH Enzymatic conversion of the antibiotic metronidazole to an analog of thiamine Arch Biochem Biophys 1987257235762 10.1016/0003-9861(87)90577-7Open DOISearch in Google Scholar

42Kapoor K, Chandra M, Nag D, Paliwal JK, Gupta RC, Saxena RC. Evaluation of metronidazole toxicity: a prospective study. Int J Clin Pharmacol Res. 1999;19(3):83–8. Kapoor K Chandra M Nag D Paliwal JK Gupta RC Saxena RC Evaluation of metronidazole toxicity: a prospective study Int J Clin Pharmacol Res 1999193838Search in Google Scholar

43Forny P, Schumann A, Mustedanagic M, Mathis D, Wulf MA, Nägele N, et al. Novel mouse models of methylmalonic aciduria recapitulate phenotypic traits with a genetic dosage effect. J Biol Chem. 2016;291(39):20563–73. doi:10.1074/jbc. M116.747717. Forny P Schumann A Mustedanagic M Mathis D Wulf MA Nägele N et al Novel mouse models of methylmalonic aciduria recapitulate phenotypic traits with a genetic dosage effect J Biol Chem 2016291392056373 10.1074/jbc.M116.747717503405027519416Open DOISearch in Google Scholar

44Lucienne M, Aguilar-Pimentel JA, Amarie OV, Becker L, Calzada-Wack J, da Silva-Buttkus P, et al. In-depth phenotyping reveals common and novel disease symptoms in a hemizygous knock- in mouse model (Mut-ko/ki) of mut-type methylmalonic aciduria. Biochim Biophys Acta Mol Basis Dis. 2020;1866(3):165622. doi:10.1016/j.bbadis.2019.165622. Lucienne M Aguilar-Pimentel JA Amarie OV Becker L Calzada-Wack J da Silva-Buttkus P et al In-depth phenotyping reveals common and novel disease symptoms in a hemizygous knock- in mouse model (Mut-ko/ki) of mut-type methylmalonic aciduria Biochim Biophys Acta Mol Basis Dis 202018663165622 10.1016/j.bbadis.2019.16562231770620Open DOISearch in Google Scholar